Cite
HARVARD Citation
Park, S. et al. (2016). Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1). European journal of cancer. pp. 42-50. [Online].